Sublytic complement attack induces cell cycle in oligodendrocytes: S phase induction is dependent on c-jun activation

Journal of Immunology

Volumn 156, Issue 12, 1996, Pages 4892-4900

  Rus, Horea G ^a   Niculescu, Florin ^a   Shin, Moon L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL DEATH; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; GENE ACTIVATION; GENE EXPRESSION; NONHUMAN; OLIGODENDROGLIA; ONCOGENE C JUN; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; COMPLEMENT MEMBRANE ATTACK COMPLEX; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA; DNA PRIMERS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GENE EXPRESSION; GENES, JUN; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; MYELIN BASIC PROTEINS; MYELIN PROTEOLIPID PROTEIN; OLIGODENDROGLIA; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; S PHASE; TRANSCRIPTION FACTOR AP-1;

EID: 0029929039     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Muller-Eberhard, H. J. 1988. Molecular organization and function of the complement system. Annu. Rev. Biochem. 57:321.
2. Shin, M. L., and D. F. Carney. 1988. Cytotoxic action and other metabolic consequences of terminal complement proteins. Prog. Allergy 40:44.
3. Bhakdi, S., and J. Tranum-Jensen. 1983. Membrane damage by complement. Biochim. Biophys. Acta. 737:343.
4. Morgan, B. P. 1989. Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem. J. 264:1.
5. Hansen, G. M. 1992. The complement attack phase: control of lysis and non-lethal effects of C5b-9. Immunopharmacology 24:107.
6. 4 generation in human polymorphonuclear leukocytes. J. Immunol. 137:1286.
7. Halperin, J. A., A. Taratuska, and A. Nicholson-Weller. 1993. Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cells. J. Clin. Invest. 91: 1974.
8. Carney, D. F., T. J. Lang, and M. L. Shin. 1990. Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination. J. Immunol. 145:623.
9. Niculescu, F., H. Rus, S. Shin, T. Lang, and M. L. Shin. 1993. Generation of diacylglycerol and ceramide during homologous complement activation. J. Immunol. 150:214.
10. Niculescu, F., H. Rus, and M. L. Shin. 1994. Receptor-independent activation of guanine nucleotide-binding regulatory-proteins by terminal complement complexes. J. Biol. Chem. 269:4417.
11. Linington, C., B. P. Morgan, N. J. Scolding, P. Wilkins, S. Piddlesden, and D. A. Compston. 1989. The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain 112:895.
12. Piddlesden, S. J., M. K. Storch, M. Hibbs, A. M. Freeman, H. Lassmann, and B. P. Morgan. 1994. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J. Immunol. 152:5477.
13. Compston, D. A., B. P. Morgan, A. K. Campbell, P. Wilkins, G. Cole, N. D. Thomas, and B. Jasani. 1989. Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropathol. Appl. Neurobiol. 15: 307.
14. Linington, C., H. Lassmann, B. P. Morgan, and D. A. Compston. 1989. Immunohistochemical localization of terminal complement component C9 in experimental allergic encephalomyelitis. Acta Neuropathol. 79:78.
15. Vanguri, P., B. A. Silverman, C. L. Koski, and M. L. Shin. 1982. Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies. Proc. Natl. Acad. Sci. USA 79:3290.
16. Cyong, J. C., S. S. Witkin, B. Rieger, E. Barbarese, R. A. Good, and N. K. Day. 1982. Antibody-independent complement activation by myelin via the classical complement pathway. J. Exp. Med. 155:587.
17. Wren, D. R., and M. Noble. 1989. Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody. Proc. Natl. Acad. Sci. USA 86: 9025.
18. Scolding, N. J., B. P. Morgan, A. Houston, A. K. Campbell, C. Linington, and D. A. S. Compston. 1989. Normal rat serum cytotoxicity against syngeneic oligodendrocytes. J. Neurol. Sci. 89:289.
19. Vanguri, P., and M. L. Shin. 1988. Hydrolysis of myelin basic protein in human myelin by terminal complement complexes. J. Biol. Chem. 263:7228.
20. 4 from sublethally injured Oligodendrocytes by terminal complement complexes. J. Neurochem. 48:271.
21. Shirazi, Y., H. G. Rus, W. B. Macklin, and M. L. Shin. 1993. Enhanced degradation of messenger RNA encoding myelin proteins by terminal complement complexes in oligodendrocytes. J. Immunol. 150:4581.
22. Goldman, J. E. 1992. Regulation of oligodendrocyte differentiation. Trends Neurosci. 15:359.
23. Raff, M. C. 1989. Glial cell diversification in the rat optic nerve. Science 243: 1450.
24. Dulic, V., E. Lees, and S. I. Reed. 1992. Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257:1958.
25. Girard, F., U. Strausfeld, A. Fernandez, and N. J. C. Lamb. 1991. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67: 1169.
26. Matsushime, H., M. E. Ewen, D. K. Strom, J.-Y. Kato, S. K. Hanks, M. F. Roussel, and C. J. Sherr. 1992. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 71:323.
27. Baldin, V., J. Lukas, M. J. Marcote, M. Pagano, and G. Draetta. 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:812.
28. Nigg, E. A. 1993. Targets of cyclin-dependent protein kinases. Curr. Opin. Cell Biol. 5:187.
29. Furukawa, Y., H. Piwnica-Worms, T. J. Ernst, Y. Kanakura, and J. D. Griffin. 1990. cdc2 gene expression at the G1 to S transition in human T lymphocytes. Science 250:805.
30. Raff, M. C., B. A. Barres, J. F. Burne, H. S. Coles, Y. Ishizaki, and M. D. Jacobson. 1993. Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262:695.
31. Groves, A. K., S. C. Barnett, R. J. M. Franklin, A. J. Crang, M. Mayer, W. F. Blakemore, and M. Noble. 1993. Repair of demyelinated lesions by transplantation of purified 0-2A progenitor cells. Nature 362:453.
32. Chirgwin, J. M., A. E. Przybyla, R. J. McDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294.
33. Thomas, P. 1980. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA 77:5201.
34. Lee, K. A. W., A. Bindereif, and M. Green. 1988. A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Anal. Technol. 5:22.
35. Coso, O. A., M. Chiariello, G. Kalinec, J. M. Kyriakis, J. Woodgett, and S. Gutkind. 1995. Transforming G-protein-coupled receptors potentially activate JNK (SAPK). J. Biol. Chem. 270:5620.
36. Modiano, J. F., J. Domenico, A. Szepesi, J. J. Lucas, and E. W. Gelfand. 1994. Differential requirements for interleukin-2 distinguish the expression and activity of the cyclin-dependent kinases Cdk4 and Cdk2 in human T cells. J. Biol. Chem. 269:32972.
37. Naeve, G. S., A. Shamra, and A. S. Lee. 1992. Identification of a 10-base pair protein binding site in the promoter of the hamster H3.2 gene required for S-phase dependent increase in transcription and its interaction with a Jun-like nuclear factor. Cell Growth Differ. 3:919.
38. Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:16483.
39. Murakami, Y., M. Satake, Y. Yamaguchi-Iwai, M. Sakai, M. Muramatsu, and Y. Ito. 1991. The nuclear protooncogenes c-jun and c-fos as regulators of DNA replication. Proc. Natl. Acad. Sci. USA 88:3947.
40. Riabowol, K., J. Schiff, and M. Z. Gilman. 1992. Transcription factor AP-1 activity is required for initiation of DNA synthesis and is lost during cellular aging. Proc. Natl. Acad. Sci. USA 89:157.
41. Olson, M. F., A. Ashworth, and A. Hall. 1995. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 269:1270.
42. Carter, R., S. C. Cosenza, A. Pena, K. Lipson, D. R. Soprano, and K. J. Soprano. 1991. A potential role for c-jun in cell cycle progression through late G1 and S. Oncogene 6:229.
43. Robbins, D. S., Y. Shirazi, B. E. Drysdale, A. Lieberman, H. S. Shin, and M. L. Shin. 1987. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J. Immunol. 139:2593.
44. Shearer, W. T., J. P. Atkinson, M. M. Frank, and C. W. Parker. 1975. Humoral immunostimulation. J. Exp. Med. 141:736.
45. Benzaquen, L. R., A. Nicholson-Weller, and J. A. Halperin. 1994. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. J. Exp. Med. 179:985.
46. Marraccino, R. L., E. J. Firpo, and J. M. Roberts. 1992. Activation of the p34 CDC2 protein kinase at the start of S phase in the human cell cycle. Mol. Biol. Cell 3:389.
47. Dalton, S. 1992. Cell cycle regulation of the human cdc2 gene. EMBO J. 11: 1797.
48. Welch, P. J., and J. Y. J. Wang. 1992. Coordinated synthesis and degradation of cdc2 in the mammalian cell cycle. Proc. Natl. Acad. Sci. USA 89:3093.
49. Loyer, P., D. Glaise, S. Cariou, G. Baffet, L. Meijer, and C. Guguen-Guillouzo. 1994. Expression and activation of cdks (1 and 2) and cyclins in the cell cycle progression during liver regeneration. J. Biol. Chem. 269:2491.
50. Kato, J. Y., and C. J. Sherr. 1993. Induction of granulocyte differentiation by G1 cyclins D2 and D3 but not D1. Proc. Natl. Acad. Sci. USA 90:11513.
51. Evan, G. I., L. Brown, M. Whyle, and E. Harrington. 1995. Apoptosis and cell cycle. Curr. Opin. Cell Biol. 7:825.
52. Ludwin, S. K. 1984. Proliferation of mature oligodendrocytes after trauma to the central nervous system. Nature 308:274.
53. Ludwin, S. K., and D. A. Bakker. 1988. Can oligodendrocytes attached to myelin proliferate? J. Neurosci. 8:1239.
54. Barres, B. A., R. Schmid, M. Sendnter, and M. C. Raff. 1993. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118:283.
55. Sanders, M. E., C. L. Koski, M. L. Shin, M. M. Frank, and K. A. Joiner. 1986. Activated terminal complement in cerebrospinal fluid in Guillane-Barré syndrome and multiple sclerosis. J. Immunol. 136:4456.